Carbapenem-Resistant Enterobacteriaceae: Epidemiology, Detection and Treatment
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: 20 May 2025 | Viewed by 146
Special Issue Editor
Interests: gut microbiome; microbiome-based therapeutics; antibiotic-resistant gram-negative bacterial infections
Special Issue Information
Dear Colleagues,
Enterobacteriaceae are a group of bacteria (germs) that are a normal part of the human and animal gut, but they can also cause infections. Carbapenem-resistant Enterobacteriaceae (CRE) are germs resistant to one or several carbapenem antibiotics. Infections caused by CRE have limited treatment options and are associated with a high mortality rate.
This Special Issue welcomes all submissions related to carbapenem-resistant Enterobacteriaceae and aims to develop more effective antibiotic stewardship and infection control measures, promote advances in the treatment of carbapenem-resistant Enterobacteriaceae, and prevent the further spread of carbapenem resistance in Enterobacteriaceae.
Dr. Seung Soon Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- carbapenem-resistant Enterobacterales (CRE)
- antibiotic treatment
- epidemiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
